High-Altitude Pulmonary Edema in Children in Mexico City: A Case Series.

Authors

Alejandro Ferreiro Marín, María Paula Ferreiro Soria, Karla Sánchez Olivera, Aranza Suárez Ortega, Luis Martín Garrido García

Published in

High altitude medicine & biology. Pages 15578682261500306. Oct 20, 2026. Epub Oct 20, 2026.

Abstract

Marín, Alejandro Ferreiro, María Paula Ferreiro Soria, Karla Sánchez Olivera, Aranza Suárez Ortega, and Luis Martín Garrido García. High-altitude pulmonary edema in children in Mexico City: A case series. High Alt Med Biol. 00:00-00, 2026.-High-altitude pulmonary edema (HAPE) is a potentially life-threatening form of noncardiogenic pulmonary edema caused by hypobaric hypoxia. Although well characterized in adults, pediatric cases remain underrecognized and are frequently mistaken for pneumonia.We describe four pediatric patients aged 7-12 years diagnosed with HAPE at a Private Tertiary Referral Medical Center in Mexico City. One patient developed classic HAPE after ascent from low altitude, and three patients developed reentry HAPE after returning to high altitude following temporary stays near sea level.All patients presented with hypoxemia (SpO₂ 77%-93%), respiratory symptoms, bilateral pulmonary infiltrates, absence of fever, and low inflammatory markers. Echocardiography demonstrated elevated or borderline elevated pulmonary artery pressures without structural heart disease. Supplemental oxygen resulted in rapid clinical improvement in all cases. Hospital stay ranged from 2 to 4 days, and none required mechanical ventilation. One patient experienced recurrence shortly after discharge.HAPE should be considered in children presenting with acute hypoxemic respiratory illness after recent ascent to high altitude. The combination of hypoxemia, bilateral infiltrates, low inflammatory markers, and rapid response to oxygen therapy may help distinguish HAPE from infectious pneumonia and facilitate timely treatment.

PMID:
42897967
Bibliographic data and abstract were imported from PubMed on 20 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.